LifeMD, Inc. LFMD
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -5.62% | -5.75% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.62% | -5.75% | |||
| Cost of Revenue | 56.11% | -10.82% | |||
| Gross Profit | -13.38% | -5.07% | |||
| SG&A Expenses | -19.68% | -8.02% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 15.47% | -4.94% | |||
| Total Operating Expenses | -9.78% | -7.92% | |||
| Operating Income | 37.35% | 20.15% | |||
| Income Before Tax | 36.90% | 20.16% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 36.90% | 20.16% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 36.90% | 20.16% | |||
| EBIT | 37.35% | 20.15% | |||
| EBITDA | 39.26% | 20.94% | |||
| EPS Basic | 33.80% | 19.28% | |||
| Normalized Basic EPS | 37.37% | 20.92% | |||
| EPS Diluted | 33.13% | 19.28% | |||
| Normalized Diluted EPS | 37.37% | 20.92% | |||
| Average Basic Shares Outstanding | 0.82% | 0.96% | |||
| Average Diluted Shares Outstanding | 0.82% | 0.96% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -0.58% | -0.25% | |||